CD3E and Splenomegaly: Surprisingly, despite the significant VLS induction by wild-type 145-2C11 (with hamster IgG1), S-CD3e-mAb did not show any notable sign of vascular leakage, splenomegaly, or body weight loss, while demonstrating expected in vivo efficacy.